SLONIN JONATHAN
Chief Medical Officer
SLONIN JONATHAN has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, SLONIN JONATHAN is listed as Chief Medical Officer at Pacira BioSciences, Inc. Inside the rolling window, SLONIN JONATHAN reported no open-market purchases and 3 open-market sales totaling $240K in PCRX. The largest disclosed transaction in the window is a sale of 3,960 PCRX shares on Nov 17, 2025, worth $95K.
Companies traded
Other insiders at PCRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$240K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has SLONIN JONATHAN made?
SLONIN JONATHAN has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does SLONIN JONATHAN trade?
SLONIN JONATHAN has filed SEC Form 4 disclosures for 1 company, including PCRX.
When was SLONIN JONATHAN's most recent SEC Form 4 filing?
SLONIN JONATHAN's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is SLONIN JONATHAN's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, SLONIN JONATHAN is listed as Chief Medical Officer.
What is SLONIN JONATHAN's total buy and sell value in the current window?
Inside the rolling retention window, SLONIN JONATHAN bought $0 and sold $240K based on SEC Form 4 filings.
What was SLONIN JONATHAN's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,960 PCRX shares on 2025-11-17, worth $95K, per SEC Form 4 filings.